Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Magrolimab + Rituximab/Chemotherapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1 & 2
Oklahoma City, Oklahoma
This trial is testing the safety and effectiveness of magrolimab, in combination with other drugs, for the treatment of lymphoma. The trial will also help to determine the best dose and schedule of magrolimab for future studies.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.